PDCD1 and non-small cell lung carcinoma: A pooled statistical analysis of randomized, controlled trials performed by Carbognin et al. indirectly compared the efficacy of PD-1 inhibitors in the treatment of NSCLC, advanced melanoma and genitourinary cancer.